Articles from Baszucki Group

Baszucki Group today announced the launch of two new initiatives across multiple sites exploring the effectiveness of ketogenic therapy for children and adolescents with bipolar disorder. The participating groups include a family resource center and four academic research institutions offering specialty programs devoted to treating serious mental illness in children and adolescents. Both programs are pioneering metabolic research with pediatric bipolar patients. These projects aim to develop ketogenic therapy programs and establish pilot data to fuel future randomized control trials and support programs in a youth population.

Baszucki Group announces a collaboration with Mayo Clinic to support a clinical trial investigating ketogenic therapy for bipolar disorder. This important study will further explore the intersection of metabolic and mental health along with cardio-metabolic implications, with the goal of informing the development of an interdisciplinary precision nutrition clinical service.

Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the study participants. Published today in BJPsych Open, the study is the first to use neuroimaging to demonstrate that a ketogenic diet may improve brain metabolism in individuals with a bipolar disorder diagnosis. With over 100 years of evidence of efficacy in epilepsy, a ketogenic diet is now being studied around the world for a variety of psychiatric and neurological conditions.